Intestinal microecology and quality of life in irritable bowel syndrome patients.

AIM It has been noticed that gastroenteritis or dysentery plays a role in pathogenesis of irritable bowel syndrome (IBS), and antibiotics can increase functional abdominal symptoms, both of which may be partly due to intestinal flora disorders. This study was to determine the change of gut flora of IBS, a cluster of abdominal symptoms. Because of the chronic course and frequent occurrence of the disease, IBS patients suffered much from it. So the quality of life (Qol) of IBS patients was also evaluated in this study. METHODS Twenty-five Rome II criteria-positive IBS patients were recruited, and 25 age and gender-matched healthy volunteers were accepted as control. The fecal flora, including Lactobacillus, Bifidobacterium, Bacteroides, C. perfringens Enterobacteriacea and Enterococus, were analyzed quantitatively and qualitatively. We also calculated the ratio of Bifidobacterium to Enterobacteriaceae (B/E ratio) in both IBS patients and controls. In both groups, the data were further analyzed based on age difference, and comparisons were made between the younger and elder subgroups. We also evaluated the quality of life (QoL) of IBS patients and the control group using the Chinese version of SF-36 health questionnaire. RESULTS In IBS patients, the number of fecal Bifidobacterium was significantly decreased and that of Enterobacteriaceae was significantly increased compared with that in healthy controls (both P<0.05). The mean microbial colonization resistance (CR) of the bowel in IBS patients was smaller than 1, making a significant difference compared with that in control which was more than 1 (P<0.01). There was no significant difference in gut flora between two subgroups. While in control, the elder subgroup presented more Enterobacteriacea than the younger one (P<0.05). Compared with the control group, IBS patients had significantly lower scores on all SF-36 scales, with the exception of physical functioning. However, there was no significant correlation between quality of life and enteric symptoms in IBS patients. CONCLUSION There are intestinal flora disorders in IBS patients, which may be involved in triggering the IBS-like symptoms. IBS patients experience significant impairment in QoL, however, the impairment is not caused directly by enteric symptoms.

[1]  K. Mikuni,et al.  Long-term ingestion of lactosucrose increases Bifidobacterium sp. in human fecal flora. , 1995, Digestion.

[2]  D. Waaij,et al.  Selective Gastrointestinal Decontamination History of recognition and measurement of colonization resistance of the digestive tract as an introduction to selective gastrointestinal decontamination , 1992, Epidemiology and Infection.

[3]  M. Mendall,et al.  Antibiotics increase functional abdominal symptoms , 2002, American Journal of Gastroenterology.

[4]  J. Cullen,et al.  Endotoxin temporarily impairs canine colonic absorption of water and sodium. , 1998, The Journal of surgical research.

[5]  D. van der Waaij.  History of recognition and measurement of colonization resistance of the digestive tract as an introduction to selective gastrointestinal decontamination. , 1992, Epidemiology and infection.

[6]  R. Lydiard,et al.  Experience with anxiety and depression treatment studies: implications for designing irritable bowel syndrome clinical trials. , 1999, The American journal of medicine.

[7]  M. Boivin.  Socioeconomic impact of irritable bowel syndrome in Canada. , 2001, Canadian journal of gastroenterology = Journal canadien de gastroenterologie.

[8]  B. Shuter,et al.  Gastroparesis and Small Bowel Dysmotility in Irritable Bowel Syndrome , 1997, Digestive Diseases and Sciences.

[9]  I. Wiklund,et al.  Health‐related quality of life and gastrointestinal disease , 2002, Journal of gastroenterology and hepatology.

[10]  Songkai Yan,et al.  Impact of Irritable Bowel Syndrome on Quality of Life and Resource Use in the United States and United Kingdom , 1999, Digestion.

[11]  H. Gooszen,et al.  The role of interdigestive small bowel motility in the regulation of gut microflora, bacterial overgrowth, and bacterial translocation in rats. , 1998, Annals of surgery.

[12]  Ulf Bengtsson,et al.  Food-Related Gastrointestinal Symptoms in the Irritable Bowel Syndrome , 2001, Digestion.

[13]  R. Spiller.  Estimating the Importance of Infection in IBS , 2003, American Journal of Gastroenterology.

[14]  K W Heaton,et al.  Functional bowel disorders and functional abdominal pain , 1999, Gut.

[15]  X. Fang,et al.  [Intestinal infection and irritable bowel syndrome]. , 2002, Zhonghua nei ke za zhi.

[16]  Colonic motility abnormality in patients with irritable bowel syndrome exhibiting abdominal pain and diarrhea. , 2001, The American journal of gastroenterology.

[17]  A. Kilbourne,et al.  The impact of irritable bowel syndrome on health-related quality of life. , 2000, Gastroenterology.

[18]  R. Pickup,et al.  Nucleic acid-based fluorescent probes in microbial ecology: application of flow cytometry. , 2000, Journal of microbiological methods.

[19]  E. Theodorsson,et al.  Endotoxin Actions on Myoelectric Activity, Transit, and Neuropeptides in the Gut (Role of Nitric Oxide) , 1997, Digestive Diseases and Sciences.

[20]  D. Savaiano,et al.  Modification of Colonic Fermentation by Bifidobacteria and pH In Vitro (Impact on Lactose Metabolism, Short-Chain Fatty Acid, and Lactate Production) , 1997, Digestive Diseases and Sciences.

[21]  Henry C. Lin,et al.  Normalization of Lactulose Breath Testing Correlates With Symptom Improvement in Irritable Bowel Syndrome: A Double-Blind, Randomized, Placebo-Controlled Study , 2003, American Journal of Gastroenterology.

[22]  M. Elia,et al.  Abnormal colonic fermentation in irritable bowel syndrome , 1998, The Lancet.

[23]  D. Silk,et al.  Impact of irritable bowel syndrome on personal relationships and working practices , 2001, European journal of gastroenterology & hepatology.